Parteck® MXP (Polyvinyl alcohol) EMPROVE ESSENTIAL Ph Eur,JPE,USP

Description

Parteck® MXP excipient is part of the Parteck® range of functional excipients developed specifically for solid dose applications. It is a particle-optimized polyvinyl alcohol designed for hot melt extrusion to increase the solubility of poorly water-soluble active pharmaceutical ingredients. Parteck® MXP excipient enables stable and high drug loads and can be used for a broad range of APIs and a variety of final dosage forms. As Emprove® Essential excipient, it is a high quality pharmaceutical excipient, offered with extensive documentation facilitating compliance, full supply chain transparency and risk mitigation.

Poor solubility of APIs is a critical challenge in drug development. One formulation technique to address this challenge is hot melt extrusion (HME). Our new Parteck® MXP is a polyvinyl alcohol-based excipient designed for hot melt extrusion to increase solubility and allow for stable and high drug loads for a broad range of APIs. The polymer  has a long safety record related to its usage in drugs and is generally recognized as safe (GRAS) by the U.S. Food and Drug Administration. Parteck® MXP complies with USP,  Ph. Eur., and JPE monographs.

Benefits of Parteck® MXP:

• Enhanced solubility of APIs
• Stable, high drug load under various conditions
• High thermo-stability (above 200 °C) and a Broad API Application Range
• Variety of final oral dosage forms with immediate or sustained release kinetics using the same extrudates
• Ease of use thanks to optimized physical properties